Amgen has been named to TIME's World's Best Companies 2026 list, rising 96 places to rank #108 among 1,000 companies worldwide.
Developed in partnership with Statista, the annual ranking evaluates companies based on employee satisfaction, revenue growth, and sustainability transparency. Together, these measures provide a broader picture of how companies are performing and preparing for the future.
The recognition comes as Amgen continues to invest in scientific innovation and the capabilities needed to advance its mission to serve patients.
A mission to serve patients drives the work
For more than 45 years, Amgen has been working to fight some of the world's toughest diseases, harnessing advances in biology and technology to develop innovative medicines.
At the heart of that work are people living with serious illnesses.
People like Jay, whose life changed after a small cell lung cancer diagnosis. Or April, who is celebrating life after leukemia. And Nancy, a former medical journalist, who found herself facing cardiovascular disease.
Their stories are reminders of why Amgen's work matters and why there is still so much more to do.
Investing in the future
Developing a medicine is only part of the challenge. Getting it to the patients who need it takes years of research, specialized expertise, and the ability to manufacture medicines reliably at scale.
Amgen continues to invest in these capabilities, from using human genetics and artificial intelligence to better understand disease to advancing the technologies used to manufacture medicines.
